KSE - Delayed Quote KRW

Suheung Co., Ltd. (008490.KS)

18,970.00
+470.00
+(2.54%)
At close: 3:30:15 PM GMT+9
Loading Chart for 008490.KS
  • Previous Close 18,500.00
  • Open 18,670.00
  • Bid 18,970.00 x --
  • Ask 19,000.00 x --
  • Day's Range 18,300.00 - 19,250.00
  • 52 Week Range 11,920.00 - 23,000.00
  • Volume 163,299
  • Avg. Volume 37,319
  • Market Cap (intraday) 210.929B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield 200.00 (1.08%)
  • Ex-Dividend Date Dec 27, 2024
  • 1y Target Est 15,000.00

Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver-treatment medicine, and nutritional supplements; and quasi-drugs, which includes low-content vitamin-cosmetic products, multi-vitamin, toothpaste, effervescent tablet, and chewable tablet. In addition, it provides its capsules under Embocaps brand name. The company was founded in 1973 and is headquartered in Cheongju-si, South Korea.

www.suheung.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 008490.KS

View More

Performance Overview: 008490.KS

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

008490.KS
49.49%
KOSPI Composite Index (^KS11)
9.42%

1-Year Return

008490.KS
14.56%
KOSPI Composite Index (^KS11)
3.62%

3-Year Return

008490.KS
45.96%
KOSPI Composite Index (^KS11)
0.52%

5-Year Return

008490.KS
61.23%
KOSPI Composite Index (^KS11)
31.39%

Compare To: 008490.KS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 008490.KS

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    205.70B

  • Enterprise Value

    596.77B

  • Trailing P/E

    10.77

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.31

  • Price/Book (mrq)

    0.45

  • Enterprise Value/Revenue

    0.89

  • Enterprise Value/EBITDA

    6.57

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.85%

  • Return on Assets (ttm)

    2.05%

  • Return on Equity (ttm)

    4.40%

  • Revenue (ttm)

    668.77B

  • Net Income Avi to Common (ttm)

    19.09B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    53.71B

  • Total Debt/Equity (mrq)

    87.78%

  • Levered Free Cash Flow (ttm)

    20.13B

Research Analysis: 008490.KS

View More

Company Insights: 008490.KS

Research Reports: 008490.KS

View More

People Also Watch